Cost ManagementManagement continues to wind down costs following the NEST-IN1 infant trial failure. Missed Efficacy EndpointThe infant study missed its primary efficacy endpoint for moderate or severe acute gastroenteritis due to the GI.1 or GII.4 norovirus genotypes, and demonstrated no secondary end...
Finance of America Companies Inc. 0.00% HX3020GI:IND $0.00 OMX Helsinki Financial Services GI 0.00% iShares Core S&P Mid-Cap ETF (IJH) Frequently Asked Questions People Also Follow SymbolLast PriceChange IJRiShares Core S&P Small-Cap ETF ...
B5510GI:IND $0.00 OMX Baltic Basic Resources GI0.00% NQMEA3010:IND $0.00 NASDAQ MEA Banks Index0.00% iShares Core S&P Mid-Cap ETF (IJH) Frequently Asked QuestionsPeople Also Follow SymbolLast PriceChange IJRiShares Core S&P Small-Cap ETF 117.15 Post....
JHML 72.25 0.44% John Hancock Multifactor Large Cap ETF DFSU 39.23 0.34% Dimensional US Sustainability Core 1 ETF TILT 223.36 0.48% FlexShares Morningstar US Market Factors Tilt Index Fund ETF Compare Similar to FSMD SymbolLast PriceChange HLGE 0 0.00% Hartford Longevity Economy ETF JPME...